|
TPR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.52479999998767E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.6180999999933E-05 |
| Normal-vs-Stage2 |
2.551400E-04 |
| Normal-vs-Stage3 |
1.9962200000001E-05 |
| Normal-vs-Stage4 |
9.199900E-04 |
| Stage1-vs-Stage2 |
6.234800E-01 |
| Stage1-vs-Stage3 |
4.952600E-01 |
| Stage1-vs-Stage4 |
9.719800E-01 |
| Stage2-vs-Stage3 |
9.913600E-01 |
| Stage2-vs-Stage4 |
7.019000E-01 |
| Stage3-vs-Stage4 |
6.501000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14689999999962E-05 |
| Normal-vs-AfricanAmerican |
2.866600E-01 |
| Normal-vs-Asian |
5.036200E-04 |
| Caucasian-vs-AfricanAmerican |
7.337600E-02 |
| Caucasian-vs-Asian |
9.626400E-01 |
| AfricanAmerican-vs-Asian |
1.001020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.158900E-04 |
| Normal-vs-Female |
4.18040000005337E-06 |
| Male-vs-Female |
9.698000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.403600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.14249999999738E-06 |
| Normal-vs-Age(61-80Yrs) |
1.195150E-04 |
| Normal-vs-Age(81-100Yrs) |
1.119750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.290800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.780200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.554000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.732000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.920000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.765600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.529600E-02 |
| Classical-VS-Follicular |
1.663880E-03 |
| Classical-VS-Other |
1.326560E-01 |
| Classical-VS-Normal |
7.247800E-04 |
| Tall-VS-Follicular |
7.910000E-01 |
| Tall-VS-Other |
4.978000E-01 |
| Tall-VS-Normal |
9.87120000000008E-05 |
| Follicular-VS-Other |
6.613200E-01 |
| Follicular-VS-Normal |
4.52029999986614E-07 |
| Other-VS-Normal |
5.660700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62979999957558E-07 |
| Normal-vs-N1 |
4.37159999999714E-05 |
| N0-vs-N1 |
7.824000E-01 |
|
|
